Yong Zhu
Professor
Faculty Researcher
CPH | Epidemiology
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Yong Zhu's research program investigates molecular mechanisms underlying cancer risk, progression, and survival, with a focus on translational applications. His laboratory examines the influence of circadian factors, including night shift work and variations in circadian genes, on tumorigenesis. Concurrently, his work delves into the translational potential of small noncoding RNAs. Zhu has authored or co-authored over 135 publications, accumulating more than 5,400 citations and an h-index of 41. His work has been recognized with a high-impact researcher designation.
He has served as PI on federal grants, including a $411,876 award from the NIH/National Cancer Institute to explore piRNAs as potential biomarkers for early ovarian cancer detection. Zhu collaborates with researchers at the University of Arkansas for Medical Sciences, including Yujuan Guo and Danny Baxter, with whom he has co-authored multiple publications. He leads a research group and maintains an active lab website.
Metrics
- h-index: 41
- Publications: 135
- Citations: 5,411
Selected Publications
-
hsa_circ_0063865 regulates cytoskeleton rearrangement and endoplasmic reticulum stress to promote esophageal tumorigenesis under co-exposure to N-nitrosamines and microcystin (2026)
-
Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer. (2026)
-
Abstract 3590: Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer. (2026)
-
Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer (2025)
-
Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening (2025)
-
Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors (2025)
Federal Grants 1 $411,876 total
Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection
Grants & Funding
As listed on this researcher's institutional profile. Federal awards with verified records are shown above.
- ABI C. OBrien NIH COBRE FY26 Y4 State of Arkansas Principal Investigator
- Zhu 2025-2027 Rural Research Award Program CI Cancer Institute Principal Investigator
Collaboration Network
Top Collaborators
- Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening
- Abstract 3590: Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer.
- Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening
- Abstract 3590: Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer.
- Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer
- Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer.
- Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer
- Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer.
- Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer
- Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer.
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening
- Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening
Similar Researchers
Based on overlapping research topics